HK1035486A1 - Immediate release oral formulation comprising peptide thrombin inhibitors and a combination of microcrystalline cellulose and sodium starch glycollate.
- Google Patents
Immediate release oral formulation comprising peptide thrombin inhibitors and a combination of microcrystalline cellulose and sodium starch glycollate.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=34632239&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1035486(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/SE1999/001471external-prioritypatent/WO2000013671A1/en
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Publication of HK1035486A1publicationCriticalpatent/HK1035486A1/en
HK01105970A1999-08-272001-08-23Immediate release oral formulation comprising peptide thrombin inhibitors and a combination of microcrystalline cellulose and sodium starch glycollate.
HK1035486A1
(en)
Immediate release oral formulation comprising peptide thrombin inhibitors and a combination of microcrystalline cellulose and sodium starch glycollate.
ORAL IMMEDIATE RELEASE FORMULA UNDERSTANDING PEPTIDIC INHIBITORS OF TROMBIN AND A COMBINATION OF MICROCRYSTALLINE CELLULOSE AND GLYCOLATE OF SODIUM STARCH
Immediate release oral formulation comprising peptide thrombin inhibitors and a combination of microcrystalline cellulose and sodium starch glycollate.